🔎 Trials Near Me

Akèy › Maladi otoim › Distrik Columbia › Washington

Etid klinik pou Maladi otoim nan Washington, DC

19 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT00867269

Natural History of Bronchiectasis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 5 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT00943514

NIAID Centralized Sequencing Protocol

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Children's National Health System, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Day – 100 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT03206099

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Ap rekriteFaz 2Volontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 4 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT02579967

Environmental Risk Factors for the Anti-synthetase Syndrome

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01276470

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 4 a 69 · Tout sèks · Mizajou Sep 28, 2026 · NCT04339777

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT04097561

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Month – 100 Years · Tout sèks · Mizajou Sep 24, 2026 · NCT00246857

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Jiska laj 99 · Tout sèks · Mizajou Sep 24, 2026 · NCT00001350

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Ap rekriteFaz 2
  • National Naval Medical Center, Bethesda · 7 mi lwen
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT00977977

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
  • American Oncology Partners of Maryland, PA, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda · 7 mi lwen
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Ap rekriteFaz 3
  • Site Number - 1024, Washington D.C.
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Jul 10, 2026 · NCT05027945

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · 7 mi lwen
  • Nih/Nhlbi, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 3 a 99 · Tout sèks · Mizajou Mar 9, 2026 · NCT04304820

X-linked Moesin Associated Immunodeficiency

Ap rekriteEtid obsèvasyon
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 4 a 80 · Gason · Mizajou Apr 25, 2025 · NCT06278337

Etid Maladi otoim nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.